Loading...

Adya solves the BIG missing piece in Cancer Care – a scalable, evidence based pathway to accelerate resiliency & rehabilitation.

We have powered our impactful platform through a collaborative platform development with Massachusetts General Hospital (MGH) - a Harvard Medical School teaching hospital and a world leader in research & care.

Who We Serve

Insurers

Poor resiliency in a cancer journey leads to slower recovery, recurring billable encounters and steep cumulative cost curves. Flatten the curve with us.

Employers

In the biggest life crisis of your employees or their loved ones, we can be their bridge back to work & achievement.
Address your massive productivity costs of Cancer – morale, disruptions, absenteeism, presenteeism.

Care Providers

We can help you bridge the chasm between cancer treatment and recovery. Extend your cancer care from episodic, transactional patient services into full continuum, value based care. 

Governments

1 of 2 of your people will suffer from cancer during their lifetime. Help them bounce back through a platform that is scalable, accessible & equitable - population wide.

Why Adya

Our Focus

We are sharply focused on accelerating cancer resiliency & recovery - at the intersection of cancer care, behavioral health & technology. We are not a vitamin. We are a painkiller.

Unmatched Science & Intellectual Property

We have powered our impactful platform through a collaborative platform development with a world leading healthcare institution. The resiliency pathways are the only ones with a 30 year track record of development, clinical care and research.

Unique Product Design

Digital engagement for cancer survivors and older age groups is a difficult problem. Our proprietary design takes away the cognitive friction. And our psychometrics, biometrics and data science capabilities power real-time personalization and evidence.

The Economics

The Costs

Lack of resiliency in cancer leads to poor & long recovery cycles.

Cumulative Direct Cost Cycle of Cancer (USA)

The Savings

Resiliency can help flatten the cost curve.

Resiliency building has indicated an average 43% reduction in billable encounters in a study of 17,601 patients over 8 years.1

The greatest reductions in utilization were found in the Hematology/Oncology category.1

Reductions are the highest in some of the most expensive functional categories / service sites.1